The Achilles heel of BCG

Tuberculosis

Volumn 90, Issue 6, 2010, Pages 329-332

  Orme, Ian M ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

BCG; Memory T cells; Tuberculosis; Vaccine

Indexed keywords

BCG VACCINE; NEUTRALIZING ANTIBODY; PLACEBO;

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELL POPULATION; CLINICAL TRIAL; DRUG EFFICACY; DRUG SCREENING; HUMAN; IMMUNE RESPONSE; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; TUBERCULOSIS; TUBERCULOUS MENINGITIS;

EID: 78049475630     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2010.06.002     Document Type: Note

References (42)

1. I.M. Orme Characteristics and specificity of acquired immunologic memory to Mycobacterium tuberculosis infection J Immunol 140 1988 3589 3593
2. I.M. Orme Evidence for a biphasic memory T-cell response to high dose BCG vaccination in mice Tubercle 69 1988 125 131
3. G.A. Colditz, T.F. Brewer, C.S. Berkey, M.E. Wilson, E. Burdick, and H.V. Fineberg Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature JAMA 271 1994 698 702
4. P.E. Fine, and L.C. Rodrigues Modern vaccines. Mycobacterial diseases Lancet 335 1990 1016 1020
5. G.A. Colditz, C.S. Berkey, F. Mosteller, T.F. Brewer, M.E. Wilson, and E. Burdick The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature Pediatrics 96 1995 29 35
6. J. Liu, V. Tran, A.S. Leung, D.C. Alexander, and B. Zhu BCG vaccines: their mechanisms of attenuation and impact on safety and protective efficacy Hum Vaccin 5 2009 70 78
7. M.A. Behr BCG-different strains, different vaccines? Lancet Infect Dis 2 2002 86 92
8. R. Brosch, S.V. Gordon, T. Garnier, K. Eiglmeier, W. Frigui, and P. Valenti Genome plasticity of BCG and impact on vaccine efficacy Proc Natl Acad Sci U S A 104 2007 5596 5601
9. A.S. Leung, V. Tran, Z. Wu, X. Yu, D.C. Alexander, and G.F. Gao Novel genome polymorphisms in BCG vaccine strains and impact on efficacy BMC Genomics 9 2008 413
10. M.A. Behr, and P.M. Small Has BCG attenuated to impotence? Nature 389 1997 133 134
11. M.A. Behr, and P.M. Small A historical and molecular phylogeny of BCG strains Vaccine 17 1999 915 922
12. M.A. Behr, M.A. Wilson, W.P. Gill, H. Salamon, G.K. Schoolnik, and S. Rane Comparative genomics of BCG vaccines by whole-genome DNA microarray Science (New York, NY 284 1999 1520 1523
13. A.S. Pym, P. Brodin, L. Majlessi, R. Brosch, C. Demangel, and A. Williams Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis Nat Med 9 2003 533 539
14. P.D. Davies Why universal BCG in UK was deemed not necessary BMJ (Clin Res Ed) 338 2009 b192
15. D.J. Lewis Unnecessary universal BCG in UK. Efficacy of BCG: three quarters full or one quarter empty? BMJ (Clin Res Ed) 338 2009 b635
16. M.R. Lagranderie, A.M. Balazuc, E. Deriaud, C.D. Leclerc, and M. Gheorghiu Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains Infect Immun 64 1996 1 9
17. C.E. Palmer, and M.W. Long Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis Am Rev Respir Dis 94 1966 553 568
18. J.L. Stanford, M.J. Shield, and G.A. Rook How environmental mycobacteria may predetermine the protective efficacy of BCG Tubercle 62 1981 55 62
19. I.M. Orme, and F.M. Collins Efficacy of Mycobacterium bovis BCG vaccination in mice undergoing prior pulmonary infection with atypical mycobacteria Infect Immun 44 1984 28 32
20. I.M. Orme, and F.M. Collins Crossprotection against nontuberculous mycobacterial infections by Mycobacterium tuberculosis memory immune T lymphocytes J Exp Med 163 1986 203 208
21. I.M. Orme, P. Andersen, and W.H. Boom T cell response to Mycobacterium tuberculosis J Infect Dis 167 1993 1481 1497
22. P. Andersen, and T.M. Doherty The success and failure of BCG - implications for a novel tuberculosis vaccine Nat Rev Microbiol 3 2005 656 662
23. M.I. Henao-Tamayo, D.J. Ordway, S.M. Irwin, S. Shang, C. Shanley, and I.M. Orme Phenotypic definition of effector and memory T-lymphocyte subsets in mice chronically infected with Mycobacterium tuberculosis Clin Vaccine Immunol 17 2010 618 625
24. hi cells after aerosol challenge with Mycobacterium tuberculosis Infect Immun 73 2005 7759 7764
25. A.W. Olsen, L. Brandt, E.M. Agger, L.A. van Pinxteren, and P. Andersen The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis Scand J Immunol 60 2004 273 277
26. F. Sallusto, A. Langenkamp, J. Geginat, and A. Lanzavecchia Functional subsets of memory T cells identified by CCR7 expression Curr Top Microbiol Immunol 251 2000 167 171
27. F. Sallusto, D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia Two subsets of memory T lymphocytes with distinct homing potentials and effector functions Nature 401 1999 708 712
28. M.J. Bevan Immunology: remembrance of things past Nature 420 2002 748 749
29. R.A. Seder, P.A. Darrah, and M. Roederer T-cell quality in memory and protection: implications for vaccine design Nat Rev 8 2008 247 258
30. C.S. Aagaard, T.T. Hoang, C. Vingsbo-Lundberg, J. Dietrich, and P. Andersen Quality and vaccine efficacy of CD4 + T cell responses directed to dominant and subdominant epitopes in ESAT-6 from Mycobacterium tuberculosis J Immunol 183 2009 2659 2668
31. T. Lindenstrom, E.M. Agger, K.S. Korsholm, P.A. Darrah, C. Aagaard, and R.A. Seder Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells J Immunol 182 2009 8047 8055
32. L. Brandt, Y.A. Skeiky, M.R. Alderson, Y. Lobet, W. Dalemans, and O.C. Turner The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs Infect Immun 72 2004 6622 6632
33. N.P. Goonetilleke, H. McShane, C.M. Hannan, R.J. Anderson, R.H. Brookes, and A.V. Hill Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara J Immunol 171 2003 1602 1609
34. A. Kamath, J.S. Woodworth, and S.M. Behar Antigen-specific CD8 + T cells and the development of central memory during Mycobacterium tuberculosis infection J Immunol 177 2006 6361 6369
35. I.M. Orme Preclinical testing of new vaccines for tuberculosis: a comprehensive review Vaccine 24 2006 2 19
36. A. Williams, Y. Hall, and I.M. Orme Evaluation of new vaccines for tuberculosis in the guinea pig model Tuberculosis (Edinb) 89 2009 389 397
37. D. Ordway, G. Palanisamy, M. Henao-Tamayo, E.E. Smith, C. Shanley, and I.M. Orme The cellular immune response to Mycobacterium tuberculosis infection in the guinea pig J Immunol 179 2007 2532 2541
38. I. Comas, J. Chakravartti, P.M. Small, J. Galagan, S. Niemann, K. Kremer, and T. Human cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved Nat Genet 42 2010 498 503
39. K. Kremer, M.J. van-der-Werf, B.K. Au, D.D. Anh, K.M. Kam, and H.R. van-Doorn Vaccine-induced immunity circumvented by typical Mycobacterium tuberculosis Beijing strains Emerg Infect Dis 15 2009 335 339
40. G.S. Palanisamy, N. DuTeau, K.D. Eisenach, D.M. Cave, S.A. Theus, and B.N. Kreiswirth Clinical strains of Mycobacterium tuberculosis display a wide range of virulence in guinea pigs Tuberculosis (Edinb) 89 2009 203 209
41. G.S. Palanisamy, E.E. Smith, C.A. Shanley, D.J. Ordway, I.M. Orme, and R.J. Basaraba Disseminated disease severity as a measure of virulence of Mycobacterium tuberculosis in the guinea pig model Tuberculosis (Edinb) 2008
42. D. Ordway, M. Henao-Tamayo, M. Harton, G. Palanisamy, J. Troudt, and C. Shanley The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation J Immunol 179 2007 522 531